Dysregulated NADPH Oxidase Promotes Bone Damage in Murine Model of Autoinflammatory Osteomyelitis

Jarmila Kralova1, Ales Drobek1,2, Jan Prochazka3,4

  • 1Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, 14220 Prague, Czech Republic.

Insights

Autoinflammatory diseases involve innate immune system dysregulation. In Pstpip2 mice, blocking NADPH oxidase reduced bone damage, revealing its role in autoinflammatory bone destruction.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Autoinflammatory diseases stem from innate immune system dysregulation, causing spontaneous inflammation.
  • The Pstpip2(cmo) mouse model exhibits autoinflammatory chronic multifocal osteomyelitis due to a PSTPIP2 adaptor protein deficiency.
  • Existing research implicates hyperproduction of IL-1β by neutrophils in this condition.

Purpose of the Study:

  • To investigate the role of PSTPIP2 in regulating reactive oxygen species (ROS) generation by neutrophil NOX2 NADPH oxidase.
  • To determine the contribution of NOX2 NADPH oxidase activity to the autoinflammatory bone destruction observed in Pstpip2(cmo) mice.

Main Methods:

  • Characterization of Pstpip2(cmo) neutrophils for superoxide production.
  • Inactivation of NOX2 NADPH oxidase in Pstpip2(cmo) mice.
  • Assessment of IL-1β levels and bone destruction kinetics.

Main Results:

  • Pstpip2(cmo) neutrophils exhibit significantly elevated superoxide production.
  • Inactivating NOX2 NADPH oxidase did not alter IL-1β levels or inflammatory onset.
  • Bone destruction was substantially alleviated upon NOX2 NADPH oxidase inactivation.

Conclusions:

  • PSTPIP2 negatively regulates ROS generation by neutrophil NOX2 NADPH oxidase.
  • Dysregulated NADPH oxidase activity, not IL-1β, is the primary driver of autoinflammatory bone damage in Pstpip2(cmo) mice.
  • Targeting NADPH oxidase may offer a therapeutic strategy for autoinflammatory bone diseases.

Related Concept Videos